
Accretion Nutraveda Ltd IPO Price Range is ₹122 - ₹129, with a minimum investment of ₹2,58,000 for 2000 shares per lot.
Minimum Investment
₹2,58,000
/ 2000 shares
IPO Status
Pre-application open
Price Band
₹122 - ₹129
Bidding Dates
Jan 28, 2026 - Jan 30, 2026
Issue Size
₹24.77 Cr
Lot Size
1000 shares
Min Investment
₹2,58,000
Listing Exchange
BSE
Experienced Promoters and Management Team.
Diverse Product Portfolio.
Commitment to Quality Standards.
Relationships with Clients and Suppliers.
Business Processes and Management Framework.
The companys manufacturing operations are subject to risks, including equipment failures, accidents, and naturaldisasters, which could disrupt production.
There are certain discrepancies and non-compliances noticed in some of its corporate records relating toforms filed with the Registrar of Companies, taxation authorities and other public authorities. Any penaltyor action taken by any regulatory authorities in future for non- compliance with provisions of allapplicable law could impact on the financial position of the Company to that extent.
The Company is dependent on few numbers of customers for sales. Loss of any of this large customermay affect its revenues and profitability.
The company has historically derived, and may continue to derives, a significant portion of its supply from top 10Suppliers.
The companys Registered Office and Factory is located on premises which are not owned by the company and has been obtainedon leased. Disruption of its rights as licensee/ lessee or termination of the agreements with the companys licensors/lessors may adversely impact its operations and, consequently,the companys business, financial condition andresults of operations.
The Company is yet to place orders for the equipment, plant and machinery for the Proposed Expansion.Any delay in placing orders or procurement of such equipment, plant and machinery may delay the scheduleof implementation and possibly increase the cost of commencing operations.
The company may faces several risks associated with the construction of the building of the Proposed Expansion,which could hamper its growth, prospects, cash flows and business and financial condition.
The Company has reported certain negative cash flows from its investing activity and financing activity,details of which are given below. Sustained negative cash flows could impact its growth and business.
The company has not made any alternate arrangements for meeting its capital requirements for the Objects of theIssue
The companys expansion into new product categories and business verticals and a substantial increase in the numberof products offered may expose the company to new challenges and more risks.